@cgconsortium.bsky.social
Cancer Genomics Consortium (CGC) is a 501(c)3 non-profit organization whose mission is to providing high quality education and promoting best practices in clinical cancer genomics.
The #CGC2026 Round Table Sessions are back this August in Houston! Join an intimate group to discuss the "how-to" of clinical genomics, from AI integration to T-Cell receptor assessment.
🔗 Link to register in the comments.
Which session are you joining? Let us know below! 👇
Join the CGC for the second webinar in the Cytogenetic Automation Series, featuring a roundtable discussion on the strengths and hurdles of adopting automated karyotyping and FISH analyses. Learn how to decrease reporting time and optimize your clinical workflow.
🔗 Register link in the comments 👇
Q34. CCND1::IGH rearrangements can be seen in all of the following, except:
A. Plasma cell myeloma
B. CLL/SLL
C. Mantle cell lymphoma
D. Non-IgM MGUS
Type your answer in the chat below and come back next week for the answer and explanation!
Register here: buff.ly/JXYPpyH
04.03.2026 16:00 — 👍 0 🔁 0 💬 0 📌 0
Registration is OPEN for the 17th Annual CGC Meeting! 🧬
📅 Aug 1-5, 2026 📍 Houston, TX + Hybrid Options 💡 Latest in Cancer Genomics & Precision Medicine ⏳ Early Bird Deadline: May 21
Don’t miss the premier event for the clinical genomics community!
Our monthly Committee Spotlight is back! This month, we are highlighting the incredible work being done by the CGC Genomic Resources Development Committee. 🧬
Click here to learn more about CGC Committees: buff.ly/vrw6doR
🚨 ONE DAY LEFT!
Tomorrow is the final day to submit your abstract for #CGC2026! If you have a draft saved in the portal, now is the time to hit submit.
⏰ Deadline: Tuesday, March 3 @ 11:59 PM PST
🔗 buff.ly/x1PGNmB
#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting
Final Days: Abstract Submissions for CGC 2026 Close Tuesday!
Planning to submit your research for the CGC 2026 Annual Meeting? This is your final weekend to polish those drafts. Submissions close this Tuesday, March 3.
🔗 Submit your abstract before the Tuesday deadline: buff.ly/x1PGNmB
Shape the Future of Genomics 🧬 CGC is calling for members to join two new Working Groups:
• Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Genomics
• Predisposition to Hematological Malignancies
📅 Apply by March 19, 2026
🔗 Link to apply in the comments👇
What resonated with you today? 🎤
Thank you to everyone who joined the CGC Early Career Committee’s Fireside Chat! We covered everything from navigating career transitions to seizing new opportunities in genomics.
Share your thoughts in the comments! 💬
#CancerGenomics #CareerGrowth #CGC
Don’t miss the #CGCAnnual2025 session: Cancer Genome Bioinformatics in a Clinical Setting!
Dr. Mark Cowley shares insights from the ZERO Childhood Cancer Program.
Dr. Sheryl Elkin discusses scalable approaches for delivering clinical information.
Watch: buff.ly/cv4ZGDr
#Genomics #CancerResearch
Q33. A young man underwent hereditary cancer testing because of family history. He was found to have a pathogenic variant in promoter region of APC. Which of the following risk is increased in this patient?
A. Attenuated colon polyps
B. Colon cancer
C. Gastric cancer
D. Osteomas
🧬 Time is running out to share your work at CGC 2026!
The Call for Abstracts is entering its final days, and we would truly love to see your research featured.
Submit soon to secure your spot: 🔗 buff.ly/YJ3KOqn
We’re pleased to share Dr. Sharon Savage’s keynote at #CGCAnnual2025.
She discusses the link between telomere biology and cancer, including research on telomere length, cancer risk, and genetic factors.
Watch: buff.ly/5v34gSC
#TelomereBiology #CancerResearch #Genomics #CGCAnnual2025 #Keynote
Type your answer in the chat below and come back next week for the answer and explanation!
17.02.2026 15:05 — 👍 0 🔁 0 💬 0 📌 0
Q33. A young man underwent hereditary cancer testing because of family history. He was found to have a pathogenic variant in promoter region of APC. Which of the following risk is increased in this patient?
A. Attenuated colon polyps
B. Colon cancer
C. Gastric cancer
D. Osteomas
Are you passionate about genomics and driven to make an impact in the cancer genomics community? The CCGA is actively recruiting new volunteers to serve as authors and mentors.
Learn more here: buff.ly/Gyobssn
🌟 Early Career Pros: Level Up! 🌟
Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned.
🗓️ 9 AM PT / 12 PM ET
🔗 buff.ly/HGgB4U1
#CancerGenomics #EarlyCareer #Mentorship
Q32. In AML with t(8;21), KIT mutations are associated with
A. Good prognosis
B. Adverse prognosis
C. Standard prognosis
D. Controversial prognosis
Check out Dr. Hagop Kantarjian’s keynote presentation at #CGCAnnual2025!
He covers molecular-genomic findings in leukemias and their diagnostic, prognostic, and therapeutic implications.
Watch here: buff.ly/s0etRp7
#Leukemia #Genomics #Diagnostics #Prognosis #Therapy
🌟 Early Career Pros: Level Up! 🌟
Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned.
🗓️ 9 AM PT / 12 PM ET
🔗 buff.ly/HGgB4U1
#CancerGenomics #EarlyCareer #Mentorship
Help us celebrate Candace Myers, PhD, FACMG , our February #CGCspotlight! ✨
We are grateful for Candace's commitment to the CGC and her contributions to the growth of the field of clinical cancer genomics.
Read her full spotlight here: buff.ly/QmHCNGr 🧬
#CGC #EarlyCareer #MemberSpotlight
🧬 Call for Abstracts: Share Your Research at CGC 2026
The #CGC2026 is now accepting abstract submissions. Showcase your: ✅ Original Research ✅ Clinical Insights ✅ Innovative Approaches
Submit your work and help shape the future of the field! 🧬👇 buff.ly/1KMMGx0
#CGCAnnual2026 #genomics #cancer
CGC & VICC: Stronger Together 🤝
Big news! The Variant Interpretation for Cancer Consortium (VICC) has officially integrated into the Cancer Genomics Consortium (CGC).
We are excited for this new chapter of collaboration and innovation!
👉 Details here: buff.ly/pIY5bd0
Q32. In AML with t(8;21), KIT mutations are associated with
A. Good prognosis
B. Adverse prognosis
C. Standard prognosis
D. Controversial prognosis
Type your answer in the chat below and come back next week for the answer and explanation!
🧬 Join our Monthly Collaborative Genomics Case Conference!
We’re back on Tuesday, Feb 10th for another deep dive into the latest in genomics. This month features two compelling case presentations you won't want to miss.
🔗 Learn more here: buff.ly/FdQRA7A
#genomics #cancer #research #genetics
🔬 Two must-see #CGCAnnual2025 talks now online!
Dr. Lisa Lansdon: Long-read sequencing to detect structural variants in pediatric leukemia.
Dr. Fritz Sedlazeck: TumorLens finds somatic variants & methylation via long-read sequencing.
Watch: buff.ly/KnxoX4Q
